rescent complexes with Tb3-EDTA. In configuration II, biotinylated probe is immobilized onto streptavidincoated wells. PCR, performed in the presence of haptenlabeled deoxyribonucleotide, generates labeled product, which is hybridized to immobilized probe and quantified as above. BCR-ABL transcripts from one leukemic cell amidst mRNA from 500 000 normal granulocytes are detectable with signal/background ratios as high as 36.4 and 24.6 for configurations I and II, respectively. The respective CVs for the assays were 6.6-9.0% and 5.1-12.5%.
Indexing Terms: leukemia/polymerase chain reaction/biotinstreptavidin interaction
The Philadelphia translocation was first described in 1960 by Nowell and Hungerford, who, while examining cells from patients with chronic granulocytic leukemia, noticed the presence of "a minute chromosome" (1) . In 1973, Rowley demonstrated that the "minute chromosome" was actually chromosome 22 with a shortened long (q) arm (2) . Not until the mid 1980s, though, was the Philadelphia (Ph1) chromosome specifically identified as the product of a reciprocal translocation involving most of the ABL protooncogene from chromosome 9 and a portion of the BCR gene from chromosome 22 [t(9;22)(q34;qll)1 (3_5) 2 Thus, it took more than 20 years for a simple observation to flower into one of the best-understood and best-documented cases of a DNA abnormality being associated with malignancy. and was incubated at room temperature for 5 mm. Before addition of the cell lysate, the magnetic beads were conditioned by washing twice with 400 tL of PBS and once with 400 tL of binding buffer. After a 5-mm incubation, in which the mRNA was allowed to hybridize with the oligo(dT)25 tails, the beads were separated from solution with use of the MPC-E magnet.
Department of Chemistry
The supernatant was removed and the beads were washed at least three times with 400 L of washing buffer (0.15 moLiL LiC1, 10 mmolIL Tris, pH 7.5, 2 mmol/L EDTA) to ensure that all other cellular RNA and protein had been removed. Lastly, to elute the mRNA from the solid phase, we resuspended the beads in 10 L of 2 mmol/L EDTA and incubated at 65#{176}C for 2 mm. The beads were then separated from solution and the eluted mRNA was quickly added to 10 L of reverse transcription reaction mixture and incubated for 1 h at 37#{176}C. This reaction mixture consisted of 100 mmol/L Tris, pH 8. Once isolated, the granulocytes were washed several times with PBS to remove all traces of the density gradient medium. The remainder of the mRNA extraction procedure was exactly as described for the K562 cells.
All solutions used in the. isolation of mRNA and cDNA synthesis were prepared with DEPC-treated water to eliminate RNase activity. Furthermore, all pipets, pipet tips, mineral oil, and solutions were irradiated with ultraviolet light in a laminar flowhood for at least 1 h to destroy any contaminating DNA carryover from previous PCR experiments.
Solutions that were irradiated were treated in glass containers, given reports that ultraviolet irradiation of solutions in polystyrene containers reduces the efficiency of PCR (21). Finally, a "no mRNA template" (negative control) was also included for each reverse transcription-PCR so that contamination could be monitored.
Oligonucleotides
Labeling oligonucleotides B and E with biotin. Oligo B, which was used as a probe in assay configuration II, and oligo E, used as a PCR primer in assay configuration I, were labeled with a 500:1 molar excess of NHS-LC-biotin at pH 9.1. We used the long-chain Polymerase Chain Reaction PCR was initiated with the "hot start" method (24), and the 48-well Perkin-Elmer Cetus (Norwalk, CT) DNA Thermal
Cycler was used. Reproducibility of identical samples was not affected by their position within the heating block. The PCR mixtures were first heated to 95#{176}C for 5 mm, during which time 2.5 U of Thermus aquaticus DNA polymerase (Taq  polymerase) was added to each tube. PCR 1 was carried out for 25 cycles, each cycle being denaturation at 95#{176}C for 30 s, primer annealing at 60#{176}C for 30 s, and primer extension at 72#{176}C for 1 mm. Finally, the reaction mixtures were held at 72#{176}C for 10 mm to allow for product reannealing and were then cooled to 4#{176}C. PCR 1 products were then diluted 50-fold in water, and 5 L of the dilution was added to each PCR 2 reaction mixture for reamplification. PCR 2 was performed in a final volume of 100 L with all reagents and conditions identical to PCR 1 except that oligo G was used as the 3' PCR 2 primer in both configurations; biotinylated oligo E and unlabeled oligo F were used as the 5' PCR 2 primers in assay configurations I and II, respectively; and 30 mo1/L dVFP and 10 .Lmo1/L DIG-dUTP were used in configu-ration II instead of 40 mo1/L dTTP. PCR 2 was run for 30 cycles in configuration I and 25 cycles in configuration II.
To summarize, PCR 1 is identical for both configurations, whereas PCR 2 is designed to produce either a biotinylated amplified product (for assay configuration I) or a DIG-labeled product (for configuration II). The total time required for both PCR 1 and 2 is -4 h. The wells were then washed three times, and 90 L of blocking solution, preheated at 42#{176}C, was pipetted into each well. PCR 2 products generated for this configuration were denatured by heating at 95#{176}C for 5 mm and immediately placed on ice. We then added in duplicate 10 L of the PCR product to the 90 L of blocking solution already present in the well. Hybridization proceeded for 30 mm at 42#{176}C, after which time we again washed the wells three times. The addition of the alkaline phosphataselabeled anti-DIG antibody and FSAP substrate and the measurement of the fluorescence produced were exactly as described for configuration I above. Total assay time for both configurations I and II, not including PCR, was 2 h.
Hybridization Assays

Results and Discussion
Assay configurations I (immobilized target) and II (immobilized probe) are illustrated in Fig. 1 . To determine the maximum fluorescence achievable, we investigated diluting the PCR 2 product before adding it to the SA-coated wells. For configuration I ( Fig. 2A) , fluorescence increased as the amount of product added increased (i.e., at lower dilutions). We chose as optimum a 10-fold dilution of the PCR 2 product, which corresponds to 10 L of the original PCR 2 mixture per well. Addition of higher quantities of product per well did not result in significant improvements of the signal because of saturating the SA binding sites. For configuration II, the signal also increased with the amount of PCR 2 product added (Fig. 2B) . Again, a 10-fold dilution was chosen as the optimum. At fivefold dilution, the fluorescence continued to increase, but the signals corresponding to 10 and 1000 cells became indistinguishable.
We attribute this to the fact that, at higher target concentrations (greater number of cells combined with a low dilution of PCR product), competition arises between target reannealing and hybridization of the denatured target to immobilized probe. Next, the time required for the hybridization reaction to occur at 42#{176}C in both assays was studied (Fig.  3) . In assay configuration I, a 10-mn hybridization period generated the greatest signal-to-background ratio, whereas assay II required 30 mm to achieve the best ratio. With longer incubation periods, the signalto-background ratio decreased because of increased nonspecific binding of the labeled reactants to the solid phase. The reasoning behind the shorter hybridization time required for assay I is that the NaOH treatment The signal-to-background ratio is the ratio of fluorescence obtained in the presence and absence of target DNA (PCR 2 product). Lines I and 2 represent 10-fold dilutions of RCA 2 product from mRNA corresponding to 100 and 10000 leukemlc cells, respectively (A) or corresponding to 10 and 1000 leukemic cells, respectively (B). removes one strand of the immobilized target so that the probe hybridizes with a single-stranded target, whereas in configuration II there is competition between probe and complementary strand. NaOH treatment did not remove SA from the solid phase nor did it disrupt the biotin-SA interaction. Figure 4A shows the effect of the concentration of the DIG-tailed probe on the signal-to-background ratios observed.
Investigation of concentrations in the range of 0.4 to 14 nmol/L showed that the signal-to-background ratios were constant in the range of 1 to 10 nmol/L.
We decided upon a final DIG-tailed probe concentration of 7.1 nmol/L and used this for further investigation for configuration I. Also, we conducted experiments to determine the optimal concentration of alkaline phosphatase-labeled anti-DIG antibody within the range 100-7500 U/L (Fig. 4B) . The signal increased with the antibody concentration, but at high concentrations the signal-to-background ratio decreased because of the higher nonspecific binding of the labeled antibody to the solid phase. A final antibody concentration of 750 UIL was ultimately chosen as the optimum for both assays I and II. To assess the reproducibility of both hybridization assays, we determined CVs for PCR 2 products generated from mRNA representative of 1, 10, and 1000 K562 cells in the presence of 500 000 normal cells. For nine replicates, configuration I produced CVs of 6.6%, 9.0%, and 7.7%, and configuration II gave CVs of 7.6%, 12.5%, and 5.1% for 1, 10, and 1000 K562 cells, respectively.
To assess the sensitivity and specificity of the proposed assays, we analyzed mixtures of mRNA from Ph'-positive cells (K562 cells) and normal granulocytes. In Fig. 5 , the signal-to-background ratio plotted vs the BCR-ABL mRNA corresponding to various numbers of K562 cells in the presence of 500 000 normal granulocytes demonstrates that one K562 cell is easily detectable, with signal-to-background ratios of 36.4 and 24.6 for assay configurations I and II, respectively. Thus, both assays offer at least 10-fold greater sensitivity (lower detection limit) than a recently reported assay for amplified mRNA that does not involve hybridization but rather detects PCR products double-labeled with biotin and DIG (25). Because only onetenth of the original PCR mixture was applied to each well, the signal represents amplified mRNA sequences from less than one cell.
The quantitative nature of the proposed assays is evident from the fact that the signal increases with the number of 1(562 cells. The curve for configuration I (Fig. 5A) begins to plateau, indicating that the solid phase has become saturated with the product. In configuration II, however (Fig. 5B) To achieve the lowest detection limit, we performed nested PCR, which does not significantly compromise the assay's practicality.
To justify the use of nested PCR, we performed experiments in which mRNA corresponding to 100 and 1000 leukemic cells in the presence of mRNA from 500 000 normal cells was amplified with a single PCR of 30 cycles and assayed by the configuration I assay. The signal-to-background ratios obtained were 1.4 and 9.5 for 100 and 1000 leukemic cells, respectively, compared with a ratio of Clinical evaluation of the proposed assays is currently in progress.
